Buy Indocin (Indomethacin 25/50/75mg) Online - Foundational Potent Indoleacetic Acid NSAID for Severe Arthritis and Gout
Indocin (Indomethacin 25/50/75mg) represents the foundational potent indoleacetic acid NSAID — one of the earliest and most powerful synthetic anti-inflammatory medications ever developed. Established by Merck Sharp & Dohme with original FDA approval in 1965, indomethacin defined the indoleacetic acid NSAID class and remains the gold standard therapy for acute gout attacks and severe inflammatory conditions requiring potent anti-inflammatory action. Manufactured by IPCA Laboratories India as bioequivalent generic under WHO-GMP and US FDA-inspected standards, Indocin offers proven potent anti-inflammatory efficacy across severe rheumatoid arthritis, moderate-to-severe osteoarthritis, gouty arthritis, ankylosing spondylitis, bursitis, and tendinitis. Available in three dose strengths including immediate release (25 mg and 50 mg capsules) and sustained release (75 mg) providing flexibility for different clinical scenarios and dosing requirements.
Indomethacin works through non-selective inhibition of cyclooxygenase (COX-1 and COX-2) enzymes — as a particularly potent prostaglandin synthesis inhibitor. Compared to newer NSAIDs, indomethacin demonstrates especially strong prostaglandin blockade which translates to superior anti-inflammatory effect for severe inflammatory conditions where lesser NSAIDs prove inadequate. Additional mechanisms include leukocyte migration inhibition, reduced neutrophil aggregation, and suppression of prostaglandin-mediated inflammatory cascade. This produces potent anti-inflammatory action, rapid pain relief, reduced joint inflammation, dramatic gout attack resolution, and improved joint mobility. Clinical response: pain relief within 30 minutes, peak effect at 1-2 hours, anti-inflammatory action within hours, and consistent therapeutic effect with regular dosing.
Indocin serves severe inflammatory pain conditions where potent NSAID therapy is required. Primary uses include rheumatoid arthritis with severe symptoms; moderate to severe osteoarthritis particularly hip and knee; acute gouty arthritis as gold standard therapy providing rapid attack resolution; ankylosing spondylitis and other spondyloarthropathies; bursitis and tendinitis particularly resistant to lesser NSAIDs; musculoskeletal pain from various causes; and specialized uses including PDA closure in neonates (patent ductus arteriosus in premature infants).
Indocin typically dosed 25-50 mg 2-3 times daily (or 75 mg SR once-twice daily) with food. Peak at 1-2 hours, 4-5 hour half-life. Higher CNS side effect profile than newer NSAIDs. IPCA Laboratories India manufactures under WHO-GMP, US FDA standards.
Free prescription
Discrete packaging
Have questions?
Quality Assurance
- Moderate to Severe Osteoarthritis: OA symptomatic treatment for severe cases particularly hip and knee;
- Gouty Arthritis: Acute gout attacks as gold standard NSAID therapy;
- Acute Gout Attack: Severe joint inflammation from urate crystal deposition;
- Ankylosing Spondylitis: Chronic inflammatory back disease responding to potent NSAID;
- Bursitis: Superficial joint bursa inflammation particularly resistant to other NSAIDs;
- Tendinitis: Tendon inflammation from various causes;
- Severe Joint Pain: Chronic joint pain requiring potent anti-inflammatory action;
- Musculoskeletal Pain: Muscle and joint pain from various inflammatory causes;
- Reactive Arthritis Reiter Syndrome: Reactive arthritis with joint inflammation;
- Psoriatic Arthritis: Psoriasis-associated arthritis responding to potent NSAID;
- Enteropathic Arthritis: IBD-associated arthritis;
- Hip Osteoarthritis: Severe hip OA responding to potent NSAID therapy;
- Knee Osteoarthritis: Severe knee OA responding to potent NSAID therapy;
- Patent Ductus Arteriosus Closure: Premature infant PDA closure (specialized pediatric use);
- Refractory Inflammatory Pain: Severe pain not responding to lesser NSAIDs;
- Indoleacetic Acid NSAID Class: Drug class with potent anti-inflammatory action;
- Foundational NSAID: 60 years clinical experience since FDA approval 1965;
- Potent Prostaglandin Inhibitor: Strong COX inhibition for severe inflammation;
- Generic Indocin Therapy: Bioequivalent generic alternative to brand-name Indocin at lower cost.
- Potent Anti Inflammatory Action: Strong prostaglandin inhibition provides superior inflammation control;
- Less Joint Pain: Severe arthritis pain decreases substantially with potent anti-inflammatory action;
- Less Joint Swelling: Active joint inflammation and swelling reduces through prostaglandin blockade;
- Less Joint Stiffness: Morning stiffness improves with potent anti-inflammatory therapy;
- Better Joint Mobility: Range of motion improves as severe inflammation decreases;
- Better Gout Attack Resolution: Acute gout attacks resolve dramatically often within 24-48 hours;
- Better Ankylosing Spondylitis Relief: Chronic back inflammation improves with potent NSAID;
- Better Rheumatoid Arthritis Control: Severe RA responds to potent anti-inflammatory action;
- Better Severe Osteoarthritis Management: Severe OA benefits from potent NSAID therapy;
- Better Bursitis Relief: Bursa inflammation improves even when resistant to lesser NSAIDs;
- Better Tendinitis Response: Tendon inflammation responds to potent anti-inflammatory therapy;
- Better Refractory Case Efficacy: Effective when other NSAIDs prove inadequate;
- Better Sustained Release Convenience: 75 mg SR provides 1-2 times daily dosing;
- Better Three Dose Flexibility: 25/50/75 mg strengths enable careful titration;
- Better Long Clinical Track Record: 60 years clinical experience since 1965;
- Better Uricosuric Effect: Minor uric acid excretion effect adjunctive for gout patients;
- Better Neonatal PDA Treatment: Specialized use for premature infant patent ductus arteriosus closure;
- Better Generic Cost: 85-95% lower cost than brand Indocin makes potent therapy accessible;
- Better Quality of Life: Daily wellbeing improves dramatically as severe inflammation resolves.
Generic Indocin (Indomethacin 25 mg) Medication guide:
Indocin (Indomethacin 25/50/75mg) is the foundational potent indoleacetic acid NSAID that established one of the most powerful synthetic anti-inflammatory therapies ever developed. Originally developed by Merck Sharp & Dohme and FDA-approved in 1965, indomethacin defined the indoleacetic acid NSAID chemical class and remains the gold standard therapy for acute gout attacks and severe inflammatory conditions requiring potent anti-inflammatory action. With over six decades of accumulated clinical experience, Indocin provides proven efficacy for severe rheumatoid arthritis, moderate-to-severe osteoarthritis, gouty arthritis, ankylosing spondylitis, bursitis, and tendinitis. This comprehensive medication guide covers every aspect of Indocin therapy from NSAID chemistry through mechanism, pharmacology, FDA safety warnings, drug interactions, patient selection, dosing strategies, and long-term management recommendations.
💊 Introduction to Indocin
Indocin is a prescription oral medication containing indomethacin as its active ingredient. Indomethacin was developed by Merck Sharp & Dohme and received FDA approval in the United States in 1965 — establishing itself as one of the earliest synthetic NSAIDs and defining the indoleacetic acid chemical class in NSAID pharmacology. When introduced, indomethacin represented a significant advance in inflammatory disease treatment providing more potent anti-inflammatory action than earlier NSAIDs (aspirin, phenylbutazone). Its distinctive potency made it particularly valuable for severe inflammatory conditions where lesser NSAIDs proved inadequate.
The medication is manufactured worldwide by numerous generic pharmaceutical companies. The version sold under the Indocin brand name on rxshop.md is manufactured by IPCA Laboratories India — an established Indian pharmaceutical company with over 70 years of manufacturing experience and US FDA-inspected facilities. IPCA maintains stringent WHO-GMP quality standards ensuring bioequivalent generic indomethacin meets the same efficacy and safety standards as brand-name Indocin. Available in three dose strengths including 25 mg and 50 mg immediate release capsules for divided daily dosing and 75 mg sustained release capsules for less frequent administration — providing flexibility for different clinical scenarios from acute severe pain requiring rapid onset to chronic conditions benefiting from simplified regimens.
Indocin occupies a distinctive position in modern NSAID therapy. While newer NSAIDs have generally replaced indomethacin as first-line therapy for common conditions like osteoarthritis and rheumatoid arthritis due to better tolerability profiles, indomethacin remains the gold standard for specific indications where its exceptional potency provides clinical advantage. In particular, acute gout attacks respond dramatically to indomethacin, often achieving substantial pain relief within 24-48 hours. Similarly, ankylosing spondylitis and other spondyloarthropathies frequently respond better to indomethacin than to lesser NSAIDs. The medication also has a specialized neonatal indication — indomethacin closes patent ductus arteriosus (PDA) in premature infants, though this pediatric use is limited to specialized neonatal intensive care settings and does not apply to the adult formulations available on rxshop.md.
🔬 Understanding NSAIDs and the Indoleacetic Acid Class
Understanding indomethacin pharmacology in the context of NSAID chemistry explains its distinctive properties, potency, and appropriate clinical use.
NSAID Chemical Classes
NSAIDs are classified by chemical structure with each class showing distinctive properties:
Major NSAID chemical classes:
- Salicylates: Aspirin, diflunisal - unique irreversible COX-1 inhibition
- Propionic acid derivatives: Ibuprofen, naproxen, ketoprofen - moderate potency, wide safety
- Phenylacetic acid derivatives: Diclofenac - moderate potency, modest COX-2 preference
- Indoleacetic acid derivatives: Indomethacin, sulindac, etodolac - high potency, more side effects
- Enolic acid derivatives (oxicams): Piroxicam, meloxicam - long half-life, once daily
- Coxibs: Celecoxib - selective COX-2, GI-sparing
Indoleacetic Acid Class Characteristics
The indoleacetic acid class introduced by indomethacin demonstrates distinctive features:
- Enhanced COX-1 and COX-2 inhibition potency - among most potent NSAIDs
- Strong anti-inflammatory action - superior for severe inflammation
- Enhanced CNS penetration - higher CNS side effect rate than most NSAIDs
- Moderate half-life - 4-5 hours for indomethacin
- Additional mechanisms beyond COX inhibition (leukocyte migration effects)
🔬 Understanding Gout — Indomethacin Gold Standard Indication
Gout is one of the most important indications for indomethacin therapy, where it serves as gold standard treatment.
Gout Pathophysiology
Gout is a metabolic disorder characterized by hyperuricemia (elevated blood uric acid) with deposition of monosodium urate crystals in joints and tissues. Acute gout attacks result from:
Acute gout attack cascade:
- Urate crystals deposit in synovial fluid of susceptible joint
- Crystals activate innate immune response
- Massive inflammatory response with cytokine release
- Neutrophil recruitment and activation
- Prostaglandin production drives pain and inflammation
- Result: severe joint pain, swelling, redness, heat
- Classic location: first metatarsophalangeal joint (podagra)
Indomethacin Gout Efficacy
Indomethacin provides dramatic gout attack response through potent prostaglandin blockade combined with additional anti-inflammatory mechanisms. Typical response:
- Onset of pain relief: Within 4-8 hours of first dose
- Substantial improvement: 24-48 hours
- Complete or near-complete resolution: 3-5 days of therapy
- Response rate: 80-90 percent significant improvement
🧬 Chemistry and Pharmacology of Indomethacin
Indomethacin has the chemical formula C19H16ClNO4 with molecular weight approximately 357.8 g/mol. Structurally, indomethacin is an indoleacetic acid derivative — specifically 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl acetic acid. The indole ring system and chlorobenzoyl group contribute to potent COX enzyme binding, while the methoxy and methyl substituents optimize pharmacokinetic properties.
Mechanism of Action
Indomethacin mechanism cascade:
- Indomethacin absorbed from GI tract reaches inflamed tissues
- Potent competitive inhibition of both COX-1 and COX-2 enzymes
- Reduced prostaglandin synthesis at inflammation sites
- Additional effects: strong inhibition of neutrophil chemotaxis
- Reduced leukocyte migration to inflammation sites
- Suppression of proinflammatory cytokine production
- Minor uricosuric effect (increased uric acid excretion) beneficial in gout
- PDA closure through prostaglandin blockade in neonates
- Result: potent anti-inflammatory action, dramatic pain relief, reduced swelling
Pharmacokinetic Profile
| Parameter | Value | Clinical Significance |
|---|---|---|
| Onset of pain relief | 30 minutes | Rapid onset for acute severe pain |
| Time to peak (Tmax) | 1 to 2 hours (IR) | Peak effect timing |
| Sustained release peak (75 mg SR) | 3 to 4 hours | Delayed peak with prolonged duration |
| Half-life | 4 to 5 hours (parent) | Requires 2-3 times daily IR dosing |
| Oral bioavailability | Nearly 100 percent | Excellent absorption |
| Protein binding | Approximately 99 percent (albumin) | Very high - potential displacement interactions |
| CNS penetration | Substantial | Higher CNS side effects than most NSAIDs |
| Metabolism | Hepatic O-demethylation deacetylation | Multiple pathways |
| Food effect | Delays absorption reduces GI upset | Take with food or milk |
| Elimination | Renal (60 percent) fecal (40 percent) | Mixed elimination pathways |
🎯 Approved Indications
FDA Approved Indications
- Rheumatoid arthritis - moderate to severe active RA
- Moderate to severe osteoarthritis
- Acute gouty arthritis - gold standard therapy
- Ankylosing spondylitis
- Acute painful shoulder - bursitis, tendinitis
- Patent ductus arteriosus closure - specialized neonatal use (IV formulation)
Off-Label Uses
- Psoriatic arthritis: Adjunctive therapy
- Reactive arthritis (Reiter syndrome)
- Enteropathic arthritis: IBD-associated arthritis
- Menstrual migraine prevention
- Pericarditis: Acute inflammation of pericardium
- Cluster headache: Acute treatment
- Trigeminal neuralgia adjunct
- Hemicrania continua and paroxysmal hemicrania
- Various rheumatic conditions
Ideal Patient Selection
Indocin therapy is most appropriate for:
- Patients with acute gout attacks requiring potent anti-inflammatory therapy
- Patients with severe inflammatory conditions not responding to lesser NSAIDs
- Ankylosing spondylitis patients where indomethacin shows superior efficacy
- Bursitis or tendinitis patients requiring potent anti-inflammatory action
- Patients without significant GI risk factors
- Patients without cardiovascular disease or high CV risk
- Patients without renal or hepatic impairment
- Adults who can tolerate CNS side effects (headache, dizziness)
- Short-term therapy preferable to long-term chronic use when possible
🚫 Contraindications
Absolute contraindications include:
- Hypersensitivity to indomethacin or other NSAIDs
- Aspirin or NSAID-induced asthma or urticaria
- Active peptic ulcer disease or GI bleeding
- Recent coronary artery bypass graft (CABG) surgery
- Severe hepatic impairment (Child-Pugh Class C)
- Severe renal impairment
- Third trimester pregnancy
- Children under 14 years (except neonatal PDA) - safety not established
Use with caution in:
- Cardiovascular disease including hypertension heart failure
- Elderly patients over 65 - increased sensitivity to all NSAID effects
- Renal impairment particularly with dehydration
- Peptic ulcer disease history
- Psychiatric disorders - CNS side effects may worsen
- Epilepsy or seizure disorders - may lower seizure threshold
- Parkinson disease - may worsen symptoms
- Concurrent anticoagulants - monitor closely
- Concurrent corticosteroids - additive GI risk
- Pregnancy first and second trimester
- Lactation - passes into breast milk
⚠️ FDA Black Box Warnings
Cardiovascular Risk Warning
FDA Black Box Warning - Cardiovascular Events:
NSAIDs including indomethacin may cause an increased risk of serious cardiovascular thrombotic events including myocardial infarction and stroke, which can be fatal. Risk increases with duration of use. Cardiovascular disease or risk factors may increase risk further.
Gastrointestinal Risk Warning
FDA Black Box Warning - Gastrointestinal Events:
NSAIDs cause an increased risk of serious GI adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. Indomethacin may have higher GI risk than some other NSAIDs due to its potency. Elderly patients are at greatest risk.
CNS Side Effect Considerations
Distinctive CNS side effect profile:
Indomethacin crosses the blood-brain barrier substantially producing higher rates of CNS side effects than most other NSAIDs. Common CNS effects include:
- Headache - very common (20-30 percent), may persist
- Dizziness and lightheadedness
- Confusion particularly in elderly
- Depression or mood changes
- Somnolence or drowsiness
- Vertigo
- Rare: seizures, hallucinations, psychosis
May limit use in patients whose occupations require full mental alertness or in elderly with cognitive concerns.
💉 Dosage and Administration
Standard Dosing by Indication
Adult standard dosing:
- Rheumatoid arthritis: 25 mg 2-3 times daily initially, may increase to 50 mg 3 times daily maximum
- Osteoarthritis: 25 mg 2-3 times daily
- Acute gout: 50 mg 3 times daily until pain relieved (usually 3-5 days), then discontinue
- Ankylosing spondylitis: 25-50 mg 2-3 times daily
- Bursitis, tendinitis: 75-150 mg daily divided 3-4 times for 7-14 days
- Sustained release (75 mg SR): Once or twice daily replacing IR dosing
- Maximum daily dose: 200 mg for most indications
SR vs IR Formulation Selection
| Formulation | Best For | Advantages |
|---|---|---|
| 25 mg IR | Initial titration, low-dose maintenance | Careful dose adjustment |
| 50 mg IR | Standard dosing, acute conditions | Rapid onset, dose flexibility |
| 75 mg SR | Chronic conditions, adherence-challenged patients | Less frequent dosing, sustained levels |
Administration Guidelines
- Take with food or milk - essential to reduce GI upset
- Take at consistent times each day
- Swallow capsules whole with full glass of water
- Do NOT crush or open SR capsules
- If dose missed, take when remembered unless close to next dose
- Use lowest effective dose for shortest duration consistent with treatment goals
- For acute conditions (gout), discontinue after resolution
- For chronic conditions, reassess periodically
- Do NOT combine with other NSAIDs or aspirin
- Consider PPI or H2 blocker gastroprotection for high-risk patients
📊 Clinical Effectiveness Data
Indomethacin has been extensively studied over more than 55 years:
| Indication | Response Rate |
|---|---|
| Acute gout attacks | 80-90 percent significant improvement in 24-48 hours |
| Rheumatoid arthritis symptoms | Substantial improvement in majority |
| Ankylosing spondylitis | Superior to lesser NSAIDs in many patients |
| Moderate-severe osteoarthritis | Significant pain and stiffness improvement |
| Bursitis and tendinitis | 70-85 percent significant response |
| Neonatal PDA closure | 70-80 percent successful closure |
| Refractory pain from other NSAIDs | Superior efficacy in many cases |
⚠️ Side Effect Profile
Common Side Effects
- Headache: Very common (20-30 percent) - most common CNS effect
- Dizziness: Common - lightheadedness particularly on rising
- GI upset: Dyspepsia, nausea, heartburn - very common
- Abdominal pain: Common
- Diarrhea or constipation: Common
- Peptic ulcer disease: Higher risk than some NSAIDs
- Tinnitus: Occasional
- Fluid retention and edema: Common
- Blood pressure elevation: Common
- Elevated liver enzymes: Occasional
- Rash: Occasional
- Confusion: Particularly in elderly
- Depression: Occasional
- Somnolence: Common
Serious Side Effects
Seek immediate medical attention for:
- Chest pain possibly suggesting myocardial infarction
- Sudden severe headache, weakness, speech difficulty possibly suggesting stroke
- Signs of GI bleeding: black tarry stools, vomiting blood, severe abdominal pain
- Severe allergic reactions: hives, facial swelling, difficulty breathing
- Severe skin reactions: rash with fever, blistering, Stevens-Johnson syndrome
- Seizures - rare but reported
- Signs of kidney injury: decreased urine output, swelling in legs
- Signs of liver injury: yellowing skin, dark urine, unusual fatigue
- Signs of heart failure: shortness of breath, ankle swelling
- Severe psychiatric symptoms: hallucinations, severe depression, psychosis
- Blood cell abnormalities: unexplained bruising, bleeding
🔄 Drug Interactions
Major Interactions
| Drug Class | Interaction |
|---|---|
| Warfarin, DOACs | Increased bleeding risk - monitor INR closely |
| Other NSAIDs, aspirin | Increased GI risk - avoid combination |
| Corticosteroids | Additive GI toxicity - avoid or use PPI |
| ACE inhibitors, ARBs | Reduced antihypertensive effect increased renal risk |
| Diuretics | Reduced diuretic effect increased renal risk |
| Lithium | Increased lithium levels risk of toxicity |
| Methotrexate | Increased methotrexate levels toxicity risk |
| Digoxin | Increased digoxin levels - monitor |
| Probenecid | Increased indomethacin levels through reduced clearance |
| Cyclosporine, tacrolimus | Increased nephrotoxicity risk |
| SSRIs and SNRIs | Additive GI bleeding risk |
| Alcohol | Additive GI bleeding risk |
🛡️ Special Populations
- Elderly Patients Over 65
- Increased sensitivity to all NSAID adverse effects particularly CNS, GI, CV, and renal. Indomethacin CNS effects (confusion, dizziness) particularly concerning. Falls risk increased. Consider alternative NSAIDs with better geriatric safety profiles when possible. If used, start at lowest dose (25 mg BID) and monitor closely.
- Pediatric Population
- Safety not established in children under 14 years. Specialized neonatal use for PDA closure only in NICU settings. Alternative NSAIDs preferred for older pediatric arthritis.
- Pregnancy
- First and second trimester: Category C - use only if benefit justifies risk. Third trimester: contraindicated due to premature ductus arteriosus closure risk (ironically the same mechanism used therapeutically for post-natal PDA closure).
- Lactation
- Passes into breast milk. Alternative NSAIDs (ibuprofen) generally preferred during breastfeeding.
- Cardiovascular Disease
- Contraindicated post-CABG. Use with caution in hypertension, heart failure, prior MI or stroke. Monitor blood pressure and CV status. Consider alternative if CV risk high.
- Renal Impairment
- NSAIDs worsen renal function. Not recommended in severe impairment. Use lowest effective dose in mild-moderate impairment with careful monitoring.
- Hepatic Impairment
- Mild-moderate: use with caution. Severe (Child-Pugh C): contraindicated.
- GI Ulcer History
- Indomethacin has higher GI risk than some NSAIDs. Avoid if possible. If necessary, use with PPI gastroprotection and monitor closely.
- Psychiatric Disorders
- Indomethacin CNS effects may worsen psychiatric conditions. Use with caution in depression, anxiety, psychosis history. Consider alternative NSAIDs.
- Parkinson Disease
- May worsen Parkinson symptoms. Alternative NSAIDs preferred when possible.
🔬 Comparison with Other NSAIDs
| Property | Indocin (Indomethacin) | Ibuprofen | Naproxen | Celecoxib |
|---|---|---|---|---|
| Class | Indoleacetic acid | Propionic acid | Propionic acid | Coxib |
| Potency | Highest among common NSAIDs | Moderate | Moderate | Moderate |
| Gout efficacy | Gold standard | Effective | Effective | Alternative |
| Ankylosing spondylitis | Preferred by many | Standard | Standard | Standard |
| GI risk | Higher than most | Standard | Higher | Lowest |
| CNS side effects | Highest (headache 20-30 percent) | Low | Low | Low |
| CV risk (moderate dose) | Moderate | Moderate | Lowest | Similar to naproxen |
| Best for | Acute gout severe AS refractory pain | Mild-moderate acute pain | CV-safer chronic use | GI-safer chronic use |
📆 Long-Term Use Considerations
Chronic Indocin therapy monitoring:
- Blood pressure monitoring: At each visit given fluid retention effects
- Renal function assessment: Annually or more often in elderly
- Liver function tests: Baseline and periodically
- Complete blood count: Periodically to monitor for anemia and cytopenias
- GI symptom assessment: At each visit
- Cardiovascular risk assessment: Annually
- Consider PPI gastroprotection: For high-risk patients
- CNS side effect assessment: Cognitive changes particularly in elderly
- Reassess ongoing need: Try dose reduction or holidays
- Consider alternative NSAIDs if adverse effects develop
📦 Storage and Handling
- Store at room temperature between 15°C and 30°C (59°F and 86°F)
- Keep in original blister packaging to protect from light and moisture
- Avoid storage in bathrooms where humidity fluctuates significantly
- Keep out of reach of children and pets
- Do not use capsules past the expiration date printed on packaging
- Return unused or expired medication to pharmacy for proper disposal
- Do not share indomethacin with others as safety considerations vary
- Maintain adequate supply for chronic therapy
👨⚕️ When to Contact Your Doctor
- Signs of cardiovascular events: chest pain, sudden weakness, speech difficulties
- Signs of GI bleeding: black stools, vomiting blood, severe abdominal pain
- Signs of allergic reaction: rash, swelling, difficulty breathing
- Signs of severe skin reactions: rash with fever, blistering
- Severe CNS effects: hallucinations, severe depression, confusion, seizures
- Signs of kidney problems: decreased urine, ankle swelling, unexplained fatigue
- Signs of liver problems: jaundice, dark urine, right upper abdominal pain
- Blood pressure elevations or worsening hypertension
- Signs of heart failure: shortness of breath, rapid weight gain, ankle swelling
- Persistent severe headache limiting function
- Persistent GI upset despite dietary measures
- Unexplained bruising or bleeding
- Persistent arthritis pain despite therapy trial
- Starting new medications especially warfarin, lithium, methotrexate
- Pregnancy planning or confirmed pregnancy
- Upcoming surgery including CABG
- Development of new medical conditions
🌟 Key Takeaways
Essential points about Indocin (indomethacin) therapy:
- Indocin is foundational potent indoleacetic acid NSAID FDA-approved in 1965
- One of the most potent non-selective COX inhibitors ever developed
- Gold standard therapy for acute gout attacks
- Superior efficacy for ankylosing spondylitis and severe inflammatory conditions
- Three dose strengths (25, 50, 75 mg SR) enable dose flexibility
- Take 25-50 mg 2-3 times daily (IR) or 75 mg 1-2 times daily (SR) with food
- Onset within 30 minutes, peak at 1-2 hours
- Also used for RA, severe OA, bursitis, tendinitis, PDA in neonates
- Higher CNS side effect profile than most NSAIDs (headache 20-30 percent)
- Higher GI risk than some other NSAIDs
- FDA Black Box warnings for cardiovascular thrombotic events and GI bleeding
- Warfarin combination requires close INR monitoring
- Multiple drug interactions including lithium, methotrexate, digoxin
- Consider PPI gastroprotection for high-risk chronic therapy patients
- Not first-line for common conditions - reserve for potent efficacy indications
Important Medical Disclaimer: This medication guide provides general information about Indocin (indomethacin) and does not constitute individualized medical advice. Every patient situation is unique and requires evaluation by a qualified healthcare provider before starting continuing adjusting or discontinuing any medication. Do not use Indocin without prescription from a qualified healthcare professional who has evaluated your specific medical situation and confirmed appropriate patient selection. This medication carries FDA Black Box warnings for cardiovascular thrombotic events and GI bleeding, with indomethacin having higher GI and CNS side effect risk than some alternative NSAIDs. Report immediately any chest pain, signs of stroke, GI bleeding, severe skin reactions, severe CNS effects, or severe allergic reactions. If you experience concerning symptoms contact your healthcare provider promptly. The information provided here should complement but never replace direct professional medical guidance.
Indocin — Frequently Asked Questions
-
What is Indocin (Indomethacin)?
Indocin is a nonsteroidal anti-inflammatory drug (NSAID) used to treat moderate to severe pain, inflammation, and stiffness caused by various conditions, including arthritis and gout. -
How does Indocin work?
It works by blocking the production of certain chemicals in the body (prostaglandins) that cause inflammation and pain. -
What conditions does Indocin treat?
Indocin is used to treat rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout, and other inflammatory conditions. -
How quickly does Indocin start working?
It usually begins to relieve pain within a few hours of taking the medication. -
How long do the effects of Indocin last?
The effects can last for 4-6 hours, depending on the dose and formulation. -
Can Indocin be used for headaches?
While not a primary use, Indocin may be prescribed off-label for certain types of headaches, like migraines, under a doctor's supervision. -
What are the side effects of Indocin?
Common side effects include gastrointestinal issues, dizziness, headache, and drowsiness. More serious side effects can include heart and kidney problems.
See all Indocin questions (32)
More Pain Medicine Medications
